Thin-layer chromatography detection method of traditional Chinese medicine compound preparation for treating irregular menstruation

Through thin-layer chromatography detection method, specific expansion agents and extraction technology were used to solve the problem of detection of Rehmannia, White Peony and Safflower in Chinese medicine compound preparations, achieving efficient and accurate detection effects, and providing a basis for the quality control of Chinese medicine compound preparations.

CN118937558AInactive Publication Date: 2024-11-12GUANGZHOU BAIYUNSHAN ZHONGYI PHARMACEUTICAL CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411324432.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-23
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The prior art lacks effective quality evaluation methods to ensure the safety and effectiveness of traditional Chinese medicine compound preparations, especially in the treatment of irregular menstruation, it is difficult to simultaneously detect the ingredients of Rehmannia, White Peony and Safflower in traditional Chinese medicine.

Method used

Thin-layer chromatography detection method was used, and the volume ratio was (10~20): (3~7): (5~15): 0.2 trichloromethane, ethyl acetate, methanol and formic acid were used as the developer, in the same thin layer. The presence of Rehmannia, white peony and safflower was detected on the plate, combined with n-butanol extraction and sonication technology, sample solution and reference solution were prepared, and the detection accuracy was improved using ultraviolet lamps and color developers.

Benefits of technology

The simultaneous detection of Rehmannia, White Peony and Saffron is achieved. The method is simple, accurate and reproducible, which reduces the experimental cost and improves the detection and identification efficiency of traditional Chinese medicine compound preparations, providing a basis for the quality control of traditional Chinese medicine compound preparations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937558A_ABST
    Figure CN118937558A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of traditional Chinese medicine analysis, in particular to a thin-layer chromatography detection method of a traditional Chinese medicine compound preparation for treating irregular menstruation. The thin-layer chromatography detection method comprises the following steps: dripping a to-be-detected sample solution, a paeoniflorin reference substance solution, a catalpol reference substance solution and a safflower reference medicinal material solution on the same thin-layer chromatography plate, developing under a developing solvent, and inspecting after developing, the developing solvent comprises trichloromethane, ethyl acetate, methanol and formic acid in a volume ratio of (10-20): (3-7): (5-15): 0.2. Under the development of the same developing solvent, the rehmannia root, the white peony root and the safflower in the traditional Chinese medicine compound preparation for treating the irregular menstruation can be simultaneously detected on the same thin-layer plate, so that the detection and identification efficiency of thin-layer chromatography of the traditional Chinese medicine compound preparation for treating the irregular menstruation is greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of traditional Chinese medicine analysis, and in particular to a thin layer chromatography detection method for a traditional Chinese medicine compound preparation for treating menstrual disorders. Background Art

[0002] Taohong Siwu Decoction is one of the 100 classic prescriptions in the "Catalogue of Ancient Classic Prescriptions (First Batch)" issued by the State Administration of Traditional Chinese Medicine. The raw materials of Taohong Siwu Decoction include angelica, rehmannia, white peony root, chuanxiong, peach kernel and safflower. It has the effects of promoting blood circulation and removing blood stasis, nourishing blood and replenishing blood. It is mainly used to treat irregular menstruation, excessive blood with clots, purple and sticky blood, abdominal pain and bloating, etc. It is clinically used for gynecological diseases caused by blood stasis, such as amenorrhea, dysmenorrhea, menopausal syndrome, infertility, chronic pelvic inflammatory disease, etc.

[0003] In order to enable the extensive clinical application of ancient classic prescriptions and to ensure their safety and effectiveness, it is very important to establish a qualitative method for their quality evaluation. Summary of the invention

[0004] Based on this, the present application provides a thin layer chromatography detection method for a Chinese medicine compound preparation for treating irregular menstruation, and its technical scheme is as follows:

[0005] A thin layer chromatography detection method for a Chinese medicine compound preparation for treating irregular menstruation comprises the following steps:

[0006] Taking a Chinese herbal compound preparation for treating irregular menstruation to be tested, preparing a sample solution to be tested, wherein the raw materials for preparing the Chinese herbal compound preparation for treating irregular menstruation to be tested include angelica sinensis, rehmannia root, white peony root, ligusticum chuanxiong, peach kernel and safflower;

[0007] preparing a paeoniflorin reference solution, a catalpol reference solution and a safflower reference medicinal material solution;

[0008] The sample solution to be tested, the paeoniflorin reference solution, the catalpol reference solution and the safflower reference medicinal material solution are spotted on the same thin layer chromatography plate, developed under a developing agent, and inspected after color development; the developing agent includes chloroform, ethyl acetate, methanol and formic acid in a volume ratio of (10-20): (3-7): (5-15): 0.2.

[0009] In some examples, the method for preparing the Chinese herbal compound preparation for treating irregular menstruation to be tested includes the following steps:

[0010] Angelica sinensis, rehmannia root, white peony root, ligusticum chuanxiong, peach kernel and safflower are mixed, water is added for extraction, the obtained extract is filtered, and the filtrate is used to prepare the Chinese medicine compound preparation for treating menstrual disorders to be tested.

[0011] In some examples, the Chinese herbal compound preparation for treating irregular menstruation is Taohong Siwu Decoction.

[0012] Optionally, the method for preparing the sample solution to be tested comprises the following steps:

[0013] The Chinese herbal compound preparation for treating irregular menstruation to be tested is extracted with an aqueous solution of n-butanol, the n-butanol phase is taken, evaporated to dryness, and then an organic solvent is added to dissolve the extracted n-butanol phase to obtain the sample solution to be tested.

[0014] Optionally, the aqueous solution of n-butanol is water-saturated n-butanol.

[0015] Optionally, the volume ratio of the Chinese herbal compound preparation for treating irregular menstruation to be tested and the aqueous solution of n-butanol is 1:(0.8-1.2).

[0016] Optionally, the organic solvent comprises methanol.

[0017] Optionally, the method for preparing the paeoniflorin reference solution comprises the following steps:

[0018] Take the paeoniflorin reference substance, add a solvent, and obtain the paeoniflorin reference substance solution.

[0019] Optionally, the solvent for preparing the paeoniflorin reference solution includes methanol.

[0020] Optionally, the concentration of paeoniflorin in the paeoniflorin reference solution is 0.5 mg / mL to 1.5 mg / mL.

[0021] Optionally, the method for preparing the catalpol reference solution comprises the following steps:

[0022] Take catalpol reference substance and add solvent to obtain catalpol reference substance solution.

[0023] Optionally, the solvent for preparing the catalpol reference solution includes methanol.

[0024] Optionally, the concentration of catalpol in the catalpol reference solution is 0.5 mg / mL to 1.5 mg / mL.

[0025] Optionally, the method for preparing the safflower control medicinal material solution comprises the following steps:

[0026] Take safflower control medicinal material, add extraction solvent, perform ultrasonic treatment, filter the obtained treatment liquid, take the filtrate and dry it, add solvent to the obtained residue to obtain safflower control medicinal material solution.

[0027] Optionally, the extraction solvent comprises n-butanol.

[0028] Optionally, the mass volume ratio of the safflower control medicinal material to the extraction solvent is 0.5 g: (20-30) mL.

[0029] Optionally, the ultrasonic treatment time is 20 min to 40 min.

[0030] Optionally, the solvent for preparing the safflower control medicinal material solution includes methanol.

[0031] Optionally, the spotting volume of the sample solution to be tested is 3 μL to 20 μL. For example, the spotting volume is 3 μL, 5 μL, 10 μL, 15 μL, or 20 μL.

[0032] Optionally, the spotting volume of the paeoniflorin reference solution is 5 μL to 20 μL. For example, the spotting volume is 5 μL, 10 μL, 15 μL, or 20 μL.

[0033] Optionally, the sample volume of the catalpol reference solution is 5 μL to 20 μL. For example, the sample volume is 5 μL, 10 μL, 15 μL, or 20 μL.

[0034] Optionally, the spotting volume of the safflower control medicinal material solution is 5 μL to 20 μL. For example, the spotting volume is 5 μL, 10 μL, 15 μL, or 20 μL.

[0035] The developing agent includes chloroform, ethyl acetate, methanol and formic acid in a volume ratio of (10-20): (3-7): (5-15): 0.2. The volume ratio of chloroform, ethyl acetate, methanol and formic acid includes but is not limited to 10:3:5:0.2, 13:4:7:0.2, 15:5:10:0.2, 17:6:13:0.2, 20:7:15:0.2. Optionally, the volume ratio of chloroform, ethyl acetate, methanol and formic acid is (13-17): (4-8): (7-13): 0.2.

[0036] Optionally, the developer used for color development includes an ethanol solution of sulfuric acid, wherein the mass proportion of sulfuric acid in the ethanol solution of sulfuric acid is 5% to 20%. For example, the mass proportion of sulfuric acid in the ethanol solution of sulfuric acid is 5%, 10%, 15%, or 20%.

[0037] Optionally, the color development temperature is 100° C. to 110° C. For example, the color development temperature is 100° C., 105° C., or 110° C.

[0038] Optionally, the review includes the following steps:

[0039] Inspecting under sunlight, observing whether spots of the same color appear at positions corresponding to the chromatogram of the paeoniflorin reference solution in the chromatogram of the sample solution to be tested;

[0040] The solution was placed under an ultraviolet lamp for inspection to see whether fluorescent spots of the same color appeared at positions corresponding to those of the chromatograms of the catalpol reference solution and the safflower reference medicinal material solution in the chromatogram of the sample solution to be tested.

[0041] Optionally, the wavelength of the ultraviolet lamp is 360nm-370nm. For example, the wavelength of the ultraviolet lamp is 360nm, 362nm, 364nm, 366nm, 368nm, 370nm.

[0042] Compared with the traditional solution, this application has the following beneficial effects:

[0043] The developing agent of the present application includes chloroform, ethyl acetate, methanol and formic acid in a volume ratio of (10-20): (3-7): (5-15): 0.2. Under the same developing agent, simultaneous detection of Rehmannia root, white peony root and safflower in a Chinese herbal compound preparation for treating irregular menstruation on the same thin layer plate can be achieved. The method is simple, accurate, reproducible and low in experimental cost, which greatly improves the detection and identification efficiency of thin layer chromatography of Chinese herbal compound preparations for treating irregular menstruation. The present application can provide a basis for the establishment of quality standards for Chinese herbal compound preparations, and is conducive to comprehensive and overall quality control and evaluation of Chinese herbal compound preparations for treating irregular menstruation. BRIEF DESCRIPTION OF THE DRAWINGS

[0044] In order to more clearly illustrate the technical solutions in the embodiments of the present application and to more completely understand the present application and its beneficial effects, the following is a brief introduction to the drawings required for the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present application, and those skilled in the art can obtain other drawings based on these drawings without creative work.

[0045] Figure 1 It is the thin layer chromatogram of the test solution, reference solution and reference medicinal material solution;

[0046] Figure 2 The thin layer chromatograms under different developing agents are shown;

[0047] Figure 3 The thin layer chromatograms are without color developer and with different color developers;

[0048] Figure 4 The thin layer chromatograms at different sample loadings are shown;

[0049] Figure 5 For thin layer chromatograms at any temperature;

[0050] Figure 6 The thin layer chromatograms at different humidity levels;

[0051] Figure 7Thin layer chromatograms under different thin layer plates. DETAILED DESCRIPTION

[0052] The present application will be further described in detail below in conjunction with specific embodiments. The present application can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the disclosure of the present application more thoroughly understood.

[0053] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which this application belongs. The terms used herein in the specification of this application are only for the purpose of describing specific embodiments and are not intended to limit this application.

[0054] the term

[0055] Unless otherwise specified or incompatible herewith, the terms and phrases used herein shall have the following meanings:

[0056] In the present application, the technical features described in an open manner include closed technical solutions composed of the listed features, and also include open technical solutions containing the listed features.

[0057] In this application, "optionally", "optional" and "optional" refer to optional, that is, to any one of the two parallel schemes of "yes" or "no". If multiple "options" appear in a technical solution, unless otherwise specified and there is no contradiction or mutual restriction, each "optional" is independent.

[0058] In this application, when it comes to numerical intervals (i.e., numerical ranges), unless otherwise specified, the optional numerical distribution is considered continuous within the above numerical interval and includes the two numerical endpoints (i.e., the minimum value and the maximum value) of the numerical range, as well as each numerical value between the two numerical endpoints. In addition, when multiple ranges are provided to describe features or characteristics, these ranges can be combined. In other words, unless otherwise specified, the ranges disclosed herein should be understood to include any and all subranges included therein.

[0059] The temperature parameters in this application, unless otherwise specified, are allowed to be either constant temperature treatment or to vary within a certain temperature range. It should be understood that the constant temperature treatment allows the temperature to fluctuate within the accuracy range controlled by the instrument. Fluctuations within the range of ±5°C, ±4°C, ±3°C, ±2°C, and ±1°C are allowed.

[0060] Thin layer chromatography is a method for micro-amount and rapid separation. Compared with high performance liquid chromatography, thin layer chromatography has the advantages of fast determination speed, short development time, simple method, low experimental cost, etc. This application conducts thin layer chromatography on a Chinese herbal compound preparation for treating irregular menstruation.

[0061] 1.1 Experimental Materials and Instruments

[0062] Linomat-VI thin layer chromatography automatic sample spotter and Reprostar 3 thin layer chromatography camera (CAMAG, Switzerland); Satorius BSA 124S-CW and Sartorius BT 25S electronic analytical balances (Sartorius Instrument System Co., Ltd., Beijing); EYELA N-3000 rotary evaporator (ELELA, Tokyo, Japan); DHG-9070A electric constant temperature blast drying oven (Shanghai Precision Experimental Equipment Co., Ltd.); KQ-250DB CNC ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); DK-S24 electric constant temperature water bath (Shanghai Jinghong Experimental Equipment Co., Ltd.). Silicone plate (HSGF254, "Huanghai" brand, Yantai Zhifu Huangwu Silicone Development and Experimental Factory, batch number: 20190907, 200×100mm); Silicone plate (HSGF254, "Yinlong" brand, Yantai Chemical Industry Research Institute, batch number: 20190528, 200×100mm); Silicone plate (SGF 254 , batch number HX185113, 10×20cm); silica gel plate (HSGF from Merck, Germany 254 , batch number HX87944542, 10×20cm).

[0063] Catalpol (batch number: 110808-201711), paeoniflorin (batch number: 110736-201943), and safflower control drug (batch number: 120907-201713) were purchased from the China Food and Drug Administration. Water was ultrapure water, and other reagents were of analytical grade.

[0064] 1.2 Preparation of test and reference substances

[0065] To avoid human factors, 15 batches of slices of each of the six medicinal materials collected and tested in the early stage were randomly sorted in the Excel table using the ENDA() function to obtain 15 random combinations. Twelve batches of them were selected as the raw material groups of 12 batches of Taohong Siwu Decoction, and were numbered P1, P2, P3...P12 in sequence. The 12 batches of Taohong Siwu Decoction research samples were used to establish the quality standard of Taohong Siwu Decoction benchmark samples. The batch numbers of the prescription medicinal materials of the 12 batches of Taohong Siwu Decoction research samples are shown in Table 1.

[0066] Table 1

[0067]

[0068] The preparation method of Taohong Siwu Decoction stock solution of each batch P1~P12 is as follows:

[0069] Weigh each batch of prescription medicinal materials according to Table 1, take 56g of Rehmannia root (washed with wine), 75g of Angelica sinensis (washed with wine), 28g of white peony root with wine, 19g of Ligusticum chuanxiong, 20g of peach kernel (peeled and pointed), and 19g of safflower (washed with wine). Add 12 times the total weight of water to the above six ingredients, boil over high heat, then simmer over low heat for 25min, decoct once, filter the extract, and add water to the filtrate to 1000mL.

[0070] 1.2.1 Preparation of test solution

[0071] Take 25 mL of Taohong Siwu Decoction stock solution (batches P1 to P12), add 25 mL of water-saturated n-butanol to extract, take the n-butanol phase and concentrate it to dryness under reduced pressure, add 1 mL of methanol to the residue to dissolve it, and use it as the test solution of batches P1 to P12.

[0072] 1.2.2 Preparation of paeoniflorin reference solution and catalpol reference solution

[0073] Take the paeoniflorin reference substance and add methanol to prepare a solution containing 1 mg of paeoniflorin reference substance per 1 mL, which is used as the paeoniflorin reference substance solution.

[0074] Take catalpol reference substance and add methanol to prepare a solution containing 1 mg of catalpol reference substance per 1 mL, which is used as the catalpol reference substance solution.

[0075] 1.2.3 Preparation of safflower control medicinal material solution

[0076] Take 0.5 g of safflower control medicinal material, add 25 mL of n-butanol, ultrasonically treat for 30 min, filter, evaporate the filtrate, add 1 mL of methanol to the residue to dissolve it, and use it as the safflower control medicinal material solution.

[0077] 1.2.4 Preparation of Rehmannia glutinosa (Wine Wash) Test Solution

[0078] Weigh the prescription medicinal materials of batch P1 of Rehmannia glutinosa (washed with wine) according to the prescription quantity in Table 1, prepare the stock solution of Rehmannia glutinosa (washed with wine) Taohong Siwu Decoction according to the preparation method of Taohong Siwu Decoction stock solution under 1.2, and prepare the test solution of Rehmannia glutinosa (washed with wine) according to the preparation method of test solution under 1.2.1.

[0079] 1.2.5 Preparation of white peony root solution lacking alcohol

[0080] Weigh the prescription medicinal materials of white peony root lacking wine of batch P1 according to the prescription quantity in Table 1, prepare the stock solution of Taohong Siwu Decoction lacking wine according to the preparation method of Taohong Siwu Decoction stock solution under 1.2, and prepare the test solution of white peony root lacking wine according to the preparation method of test solution under 1.2.1.

[0081] 1.2.6 Preparation of test solution lacking safflower (washed with wine)

[0082] Weigh the prescription medicinal materials of batch P1 of safflower (washed with wine) according to the prescription quantity in Table 1, prepare the stock solution of Taohong Siwu Decoction with White Peony Root and Lack of Wine according to the preparation method of Taohong Siwu Decoction stock solution under 1.2, and prepare the test solution of safflower (washed with wine) according to the preparation method of test solution under 1.2.1.

[0083] 1.3 Thin layer chromatography detection

[0084] According to the general method of thin layer chromatography (General Rule 0502), 5 μL of each of the catalpol reference solution, paeoniflorin reference solution, and safflower reference medicinal material solution under 1.2.2 and 3 μL of each of the test sample solutions of batches P1 to P12 under 1.2.1 were taken and spotted on the same silica gel G thin layer plate, respectively, using chloroform-ethyl acetate-methanol-formic acid (volume ratio 15:5:10:0.2) as the developing agent, developing, taking out, drying, spraying with 10% sulfuric acid ethanol solution by mass, and heating at 105°C until the spots are clearly colored. When examined under sunlight, spots of the same color appear in the chromatogram of the test solution at the corresponding position of the chromatogram of the paeoniflorin reference substance, as shown in FIG. Figure 1 A-1; then put it under ultraviolet light (366nm) for inspection, in the chromatogram of the test solution, at the corresponding position of the chromatogram of the catalpol reference substance and the safflower reference medicinal material, a fluorescent spot of the same color appears. Figure 1 A-2. Figure 1 Among them, S1 is the chromatogram of catalpol reference substance; S2 is the chromatogram of paeoniflorin reference substance; S3 is the chromatogram of safflower reference medicinal material; 1-12 are the chromatograms of 12 batches of test sample solutions.

[0085] 1.4 Methodological considerations

[0086] 1.4.1 Investigation of developing agents

[0087] Chloroform-methanol-glacial acetic acid-water (volume ratio of 20:10:3:1), ethyl acetate-methanol-formic acid-water (volume ratio of 14:3:1:1.8), and chloroform-ethyl acetate-methanol-formic acid (volume ratio of 15:5:10:0.2) were used as developing solvents, and the inspection results under different developing solvents were investigated.

[0088] Pipette 5 μL each of the catalpol reference solution and paeoniflorin reference solution under 1.2.2, and the safflower reference medicinal material solution under 1.2.3, and 3 μL each of the P1 batch test solution under 1.2.1, the preparation of the test solution lacking Rehmannia glutinosa (washed with wine) under 1.2.4, the preparation of the test solution lacking white peony root (washed with wine) under 1.2.5, and the preparation of the test solution lacking safflower (washed with wine) under 1.2.6, and develop them in the above-mentioned different developing agents according to the method under 1.3. Check the results. Figure 2 . Figure 2 A-1 and A-2 are the inspection results under sunlight and ultraviolet light at 366nm with chloroform-methanol-glacial acetic acid-water (20:10:3:1) as the developing solvent, respectively; B-1 and B-2 are the inspection results under sunlight and ultraviolet light at 366nm with ethyl acetate-methanol-formic acid-water (14:3:1:1.8) as the developing solvent, respectively; C-1 and C-2 are the inspection results under sunlight and ultraviolet light at 366nm with chloroform-ethyl acetate-methanol-formic acid (15:5:10:0.2) as the developing solvent, respectively; among them, S1 is the chromatogram of catalpol reference substance; S2 is the chromatogram of paeoniflorin reference substance; S3, safflower reference medicinal material chromatogram; 1 is the chromatogram of P1 batch test sample solution; 2 is the chromatogram of test sample solution lacking Rehmannia glutinosa; 3 is the chromatogram of test sample solution lacking Paeonia lactiflora; 4 is the chromatogram of test sample solution lacking safflower.

[0089] The results show that:

[0090] (1) When chloroform-methanol-glacial acetic acid-water (20:10:3:1) is used as the developing solvent, after color development, when examined under sunlight, a spot of the paeoniflorin reference substance can be seen at the corresponding position in the chromatogram of the test sample. Figure 2 A-1; then placed under ultraviolet light at 366nm for inspection, in the chromatogram of the test sample, spots of catalpol reference substance and safflower reference medicinal material can be seen at the corresponding positions, but in the chromatogram of the test sample of Rehmannia glutinosa, there are interference spots at the corresponding positions of catalpol, as shown in Figure 2 A-2.

[0091] (2) When ethyl acetate-methanol-formic acid-water (14:3:1:1.8) is used as the developing solvent, after color development, when examined under sunlight, a spot of the paeoniflorin reference substance can be seen at the corresponding position in the chromatogram of the test sample. Figure 2 B-1; then examine under ultraviolet light at 366nm, the catalpol reference substance spot can be seen at the corresponding position in the chromatogram of the test sample, but it overlaps with other spots at the safflower reference medicinal material. Figure 2 B-2.

[0092] (3) When chloroform-ethyl acetate-methanol-formic acid (15:5:10:0.2) is used as the developing solvent, after color development, when examined under sunlight, a spot of the paeoniflorin reference substance can be seen at the corresponding position in the chromatogram of the test sample. Figure 2C-1; then check under ultraviolet light at 366nm, spots of catalpol reference substance and safflower reference medicinal materials can be seen at the corresponding positions in the chromatogram of the test sample, and there is no interference from the tasteless test solution, the bands are clearer and the separation is good, R f The value is appropriate, see Figure 2 C-2.

[0093] Therefore, chloroform-ethyl acetate-methanol-formic acid (15:5:10:0.2) was selected as the TLC identification developer for Carthamus tinctorius, Paeonia lactiflora, and Rehmannia glutinosa.

[0094] 1.4.2 Investigation of color developer

[0095] The 10% sulfuric acid ethanol solution and the 5% vanillin sulfuric acid solution were used as colorimetric agents. The former is a universal colorimetric agent that can color most compounds in traditional Chinese medicine; the latter is a colorimetric agent for thin-layer identification of paeoniflorin in the 2020 edition of the Chinese Pharmacopoeia. The inspection results of different colorimetric agents were investigated. In addition, the results of inspection under ultraviolet light at 254nm and 366nm were also investigated when no colorimetric agent was used.

[0096] Pipette 5 μL each of the catalpol reference solution and paeoniflorin reference solution under 1.2.2, and the safflower reference medicinal material solution under 1.2.3, and 3 μL each of the P1 batch test solution under 1.2.1, the preparation of the test solution lacking Rehmannia glutinosa (washed with wine) under 1.2.4, the preparation of the test solution lacking white peony root (washed with wine) under 1.2.5, and the preparation of the test solution lacking safflower (washed with wine) under 1.2.6. Develop and inspect the samples according to the method under 1.3 under the above-mentioned different color developers and inspection conditions. The inspection results are shown in Table 1. Figure 3 . Figure 3 A is the inspection result under ultraviolet lamp at 254nm when no color developer is used; A is the inspection result under ultraviolet lamp at 366nm when no color developer is used; C is the inspection result under sunlight with 10% ethanol sulfate as the color developer; D is the inspection result under ultraviolet lamp at 366nm with 10% ethanol sulfate as the color developer; D is the inspection result under sunlight with 5% vanillin sulfuric acid as the color developer; Among them, S1 is the chromatogram of catalpol reference substance; S2 is the chromatogram of paeoniflorin reference substance; S3 is the chromatogram of safflower reference medicinal material; 1 is the chromatogram of P1 batch test sample solution; 2 is the chromatogram of test sample solution lacking Rehmannia glutinosa; 3 is the chromatogram of test sample solution lacking Paeonia lactiflora; 4 is the chromatogram of test sample solution lacking safflower.

[0097] The results show that:

[0098] (1) When no color developer is used, the chromatogram of the test solution is examined under ultraviolet light at 254nm and 366nm. No obvious spots of the paeoniflorin reference substance, catalpol reference substance or safflower reference substance are found. Figure 3 A and B.

[0099] (2) After spraying with 10% sulfuric acid ethanol for color development, the sample was examined under sunlight. At the corresponding position in the chromatogram of the test sample, a spot of the paeoniflorin reference substance was visible (see Figure 3 C); then place it under ultraviolet light at 366nm for inspection, in the chromatogram of the test solution, the corresponding spots of catalpol reference substance, paeoniflorin reference substance and safflower reference medicinal material can be observed at the same time, and R f The value is appropriate, see Figure 3 D.

[0100] (2) After spraying with 5% vanillin sulfuric acid for color development, the sample was examined under sunlight. Only spots of paeoniflorin were observed at the corresponding positions in the chromatogram of the sample. Figure 3 E.

[0101] Therefore, 10% sulfuric acid ethanol was selected as the color developer. After color development, the samples were examined under sunlight and ultraviolet light (366 nm).

[0102] 1.4.3 Investigation of the amount of sample

[0103] Take 0.5, 1, 3, 5, 10, 15, 20 μL of the catalpol reference solution under 1.2.2 and spot it on the same thin layer plate, take 0.5, 1, 3, 5, 10, 15, 20 μL of the paeoniflorin reference solution under 1.2.2 and spot it on the same thin layer plate, take 0.5, 1, 3, 5, 10, 15, 20 μL of the safflower reference medicinal material solution under 1.2.3 and spot it on the same thin layer plate, and take 0.5, 1, 3, 5, 10, 15, 20 μL of the P1 batch test solution under 1.2.1 and spot it on the same thin layer plate. Investigate the inspection results under different spotting amounts.

[0104] According to the method under 1.3, at the above different spot sample amounts, the inspection results are shown in Figure 4 . Figure 4 A is the inspection result of different sample amounts of catalpol reference substance under UV light 366nm; B is the inspection result of different sample amounts of paeoniflorin reference substance under sunlight; C is the inspection result of different sample amounts of safflower reference medicinal material under UV light 366nm; D-1 and D-2 are the inspection results of different sample amounts of test solution under UV light 366nm and sunlight, respectively. Among them, 1 is 0.5μL; 2 is 1μL; 3 is 3μL; 4 is 5μL; 5 is 10μL; 6 is 15μL; 7 is 20μL.

[0105] The results showed that the spots of 5μL of catalpol reference solution, paeoniflorin reference solution and safflower reference medicinal material solution were clear enough; the spots of 3μL of the test solution were clear enough.

[0106] Therefore, the spotting volume of catalpol reference solution, paeoniflorin reference solution and safflower reference medicinal material solution was selected as 5 μL, and the spotting volume of the test solution was selected as 3 μL as the spotting volume for thin layer identification.

[0107] 1.4.4 Durability Examination

[0108] 1.4.4.1 Temperature

[0109] The thin layer was unfolded at 4°C and room temperature (25°C) respectively to investigate the thin layer unfolding at different temperatures.

[0110] Pipette 5 μL each of the catalpol reference solution and paeoniflorin reference solution under 1.2.2, and the safflower reference medicinal material solution under 1.2.3, and 3 μL each of the P1 batch test solution under 1.2.1, the preparation of the test solution lacking Rehmannia glutinosa (washed with wine) under 1.2.4, the preparation of the test solution lacking white peony root (washed with wine) under 1.2.5, and the preparation of the test solution lacking safflower (washed with wine) under 1.2.6, and develop them at the above different temperatures according to the method under 1.3. Check the results. Figure 5 . Figure 5 A-1 is the inspection result developed at 4°C; B-1 is the inspection result developed at 25°C. Among them, S1 is the chromatogram of the catalpol reference substance; S2 is the chromatogram of the paeoniflorin reference substance; S3 is the chromatogram of the safflower reference medicinal material; 4 is the chromatogram of the P1 batch test solution; 5 is the chromatogram of the test solution lacking Rehmannia glutinosa; 6 is the chromatogram of the test solution lacking Paeonia lactiflora; 7 is the chromatogram of the test solution lacking safflower.

[0111] The results showed that the spots were very clear when developed at 4℃ and room temperature (25℃). f The values ​​are not much different, and the separation is good, which shows that temperature has no significant effect on its development effect.

[0112] 1.4.4.2 Humidity

[0113] The thin layer was developed under a relative humidity of 58% and 38% respectively to investigate the thin layer development under different humidity. The relative humidity of 58% is the normal humidity of the thin layer, and the relative humidity of 38% is the humidity after the thin layer is dried.

[0114] Pipette 5 μL of each of the catalpol reference solution and paeoniflorin reference solution under 1.2.2 and the safflower reference medicinal material solution under 1.2.3, and 3 μL of each of the P1 batch test solution under 1.2.1, the preparation of the test solution lacking Rehmannia glutinosa (washed with wine) under 1.2.4, the preparation of the test solution lacking white peony root (washed with wine) under 1.2.5, and the preparation of the test solution lacking safflower (washed with wine) under 1.2.6. Follow the method under 1.3 and develop at the above different humidity levels. Check the results. Figure 6 . Figure 6 A-1 is the inspection result carried out at a relative humidity of 58%; B-1 is the inspection result carried out at a relative humidity of 38%. Among them, S1 is the chromatogram of the catalpol reference substance; S2 is the chromatogram of the paeoniflorin reference substance; S3 is the chromatogram of the safflower reference medicinal material; 4 is the chromatogram of the P1 batch test solution; 5 is the chromatogram of the test solution lacking Rehmannia glutinosa; 6 is the chromatogram of the test solution lacking Paeonia lactiflora; 7 is the chromatogram of the test solution lacking safflower.

[0115] The results show that there is no significant difference in the strips under these two humidity conditions, and both can achieve good results, indicating that humidity has little effect on the thin layer development effect.

[0116] 1.4.5 Inspection of thin layer plates

[0117] In the "Yinlong" brand HSGF 254 , "Huanghai" brand HSGF 254 、Merck HSGF, Germany 254 、Merck SGF 254 The thin layer expansion under different thin layer plates was investigated.

[0118] Pipette 5 μL each of the catalpol reference solution and paeoniflorin reference solution under 1.2.2, and the safflower reference medicinal material solution under 1.2.3, and 3 μL each of the test solution of batches P1 to P12 under 1.2.1, the preparation of the test solution lacking Rehmannia glutinosa (washed with wine) under 1.2.4, the preparation of the test solution lacking white peony root (washed with wine) under 1.2.5, and the preparation of the test solution lacking safflower (washed with wine) under 1.2.6, and develop them under the above-mentioned different thin layer plates according to the method under 1.3. Check the results. Figure 7 . Figure 7 A-1 and A-2 are "Silver Dragon" brand HSGF 254 The inspection results are shown below; B-1 and B-2 are "Huanghai" brand HSGF 254 The inspection results are shown below; C-1 and C-2 are Merck HSGF from Germany 254 The following is the inspection result; D-1 and D-2 are Merck SGF 254 The inspection results are shown below. Among them, S1 is the chromatogram of the catalpol reference substance; S2 is the chromatogram of the paeoniflorin reference substance; S3 is the chromatogram of the safflower reference medicinal material; 1-12 are the chromatograms of 12 batches of test solution.

[0119] The results showed that: HSGF of Merck, Germany 254 and SGF 254 HSGF of "Yinlong" brand produced by Yantai Chemical Industry Research Institute and "Huanghai" brand produced by Yantai Jiangyou Silicone Development Co., Ltd. 254The thin-layer plates can be used for qualitative identification of catalpol in Rehmannia glutinosa, paeoniflorin in white peony root and safflower as a control drug, and there is no significant difference in the banding of each component, with clear bands and R f Moderate and good separation can meet the test requirements.

[0120] Based on the above experimental results, it is shown that the thin layer identification method established in this application has clear bands and R f The value is moderate, the operation is simple, and the repeatability is good. It can be used as a thin layer identification method for identifying safflower (washed with wine), white peony root (washed with wine), and rehmannia root (washed with wine) in the benchmark sample of Taohong Siwu Decoction.

[0121] In summary, this application conducts thin layer chromatography detection on a Chinese herbal compound preparation for treating irregular menstruation, and the developing agents used include chloroform, ethyl acetate, methanol and formic acid in a volume ratio of (10-20): (3-7): (5-15): 0.2. Under the same developing agent and thin layer plate, simultaneous detection of Rehmannia root, white peony root and safflower in the Chinese herbal compound preparation for treating irregular menstruation on the same thin layer plate can be achieved. The method is simple, accurate, reproducible and low in experimental cost, which greatly improves the detection and identification efficiency of thin layer chromatography of the Chinese herbal compound preparation for treating irregular menstruation. This application can provide a basis for the establishment of quality standards for Chinese herbal compound preparations, and is conducive to comprehensive and overall quality control and evaluation of Chinese herbal compound preparations for treating irregular menstruation.

[0122] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0123] The above-mentioned embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent of the present application shall be subject to the attached claims.

Claims

1. A thin layer chromatography detection method for a Chinese herbal compound preparation for treating irregular menstruation, It is characterized in that The following steps are involved: Taking a Chinese herbal compound preparation for treating irregular menstruation to be tested, preparing a sample solution to be tested, wherein the raw materials for preparing the Chinese herbal compound preparation for treating irregular menstruation to be tested include angelica sinensis, rehmannia root, white peony root, ligusticum chuanxiong, peach kernel and safflower; preparing a paeoniflorin reference solution, a catalpol reference solution and a safflower reference medicinal material solution; The sample solution to be tested, the paeoniflorin reference solution, the catalpol reference solution and the safflower reference medicinal material solution are spotted on the same thin layer chromatography plate, developed under a developing agent, and inspected after color development; the developing agent includes chloroform, ethyl acetate, methanol and formic acid in a volume ratio of (10-20): (3-7): (5-15): 0.

2.

2. The thin layer chromatography detection method of the Chinese medicinal compound preparation for treating menstrual disorders according to claim 1, It is characterized in that The volume ratio of chloroform, ethyl acetate, methanol and formic acid is (13-17): (4-8): (7-13): 0.

2.

3. The thin layer chromatography detection method of the Chinese medicinal compound preparation for treating menstrual disorders according to claim 1, It is characterized in that The method for preparing the sample solution to be tested comprises the following steps: The Chinese herbal compound preparation for treating irregular menstruation to be tested is extracted with an aqueous solution of n-butanol, the n-butanol phase is taken, evaporated to dryness, and then an organic solvent is added to dissolve the extracted n-butanol phase to obtain the sample solution to be tested.

4. The thin layer chromatography detection method of the Chinese medicinal compound preparation for treating menstrual disorders according to claim 3, It is characterized in that The organic solvent includes methanol.

5. The thin layer chromatography detection method of the Chinese herbal compound preparation for treating menstrual disorders according to claim 1, It is characterized in that The inspection includes the following steps: Inspecting under sunlight, observing whether spots of the same color appear at positions corresponding to the chromatogram of the paeoniflorin reference solution in the chromatogram of the sample solution to be tested; The solution was placed under an ultraviolet lamp for inspection to see whether fluorescent spots of the same color appeared at positions corresponding to those of the chromatograms of the catalpol reference solution and the safflower reference medicinal material solution in the chromatogram of the sample solution to be tested.

6. The thin layer chromatography detection method of the Chinese medicinal compound preparation for treating menstrual disorders according to claim 5, It is characterized in that The wavelength of the ultraviolet lamp is 360nm~370nm.

7. The thin layer chromatography detection method of the Chinese herbal compound preparation for treating menstrual disorders according to any one of claims 1 to 6, It is characterized in that The color developing agent used for color development includes an ethanol solution of sulfuric acid, and the mass proportion of sulfuric acid in the ethanol solution of sulfuric acid is 5% to 20%.

8. The thin layer chromatography detection method of the Chinese herbal compound preparation for treating menstrual disorders according to any one of claims 1 to 6, It is characterized in that The color development temperature is 100℃~110℃.

9. The thin layer chromatography detection method of the Chinese herbal compound preparation for treating menstrual disorders according to any one of claims 1 to 6, It is characterized in that Includes at least one of the following features: (1) The sample solution to be tested has a spot volume of 3 μL to 20 μL; (2) The spotting volume of the paeoniflorin reference solution is 5 μL~20 μL; (3) The sample volume of the catalpol reference solution is 5 μL~20 μL; (4) The spotting volume of the safflower control medicinal material solution is 5 μL~20 μL.

10. The thin layer chromatography detection method of the Chinese herbal compound preparation for treating menstrual disorders according to any one of claims 1 to 6, It is characterized in that Includes at least one of the following features: (1) The solvent for preparing the paeoniflorin reference solution includes methanol; (2) The solvent for preparing the catalpol reference solution includes methanol; (3) The solvent for preparing the safflower control medicinal material solution includes methanol.

Citation Information

Patent Citations

  • Method for detecting quality of Chinese medicinal preparation for treating diabetic retinopathy

    CN101672834A

  • Quality control method of Chinese medicinal preparation for regulating menstruation in Department of Obstetrics and Gynecology

    CN102028839A

  • One-plate double-medicinal-material multi-information rapid thin-layer identification method for Gentongping tablet

    CN111521725A

  • Detection method of peach kernel and safflower four-drug decoction prescription

    CN114924021A

  • Developing solvent for thin-layer identification method of peach kernel and safflower four-material decoction and thin-layer identification method

    CN114942297A